Viewing Study NCT06178159


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2025-12-27 @ 3:01 AM
Study NCT ID: NCT06178159
Status: RECRUITING
Last Update Posted: 2025-10-01
First Post: 2023-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module